Prestige Consumer Healthcare (PBH) Competitors $61.93 +0.09 (+0.14%) Closing price 10/14/2025 03:58 PM EasternExtended Trading$61.86 -0.07 (-0.11%) As of 10/14/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PBH vs. IPAR, HLF, NUS, USNA, NATR, MED, VERU, EL, BAX, and BIOShould you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Baxter International (BAX), and Bio-Rad Laboratories (BIO). Prestige Consumer Healthcare vs. Its Competitors Interparfums Herbalife Nu Skin Enterprises USANA Health Sciences Nature's Sunshine Products MEDIFAST Veru Estee Lauder Companies Baxter International Bio-Rad Laboratories Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations. Does the media favor PBH or IPAR? In the previous week, Prestige Consumer Healthcare and Prestige Consumer Healthcare both had 8 articles in the media. Prestige Consumer Healthcare's average media sentiment score of 1.02 beat Interparfums' score of 0.93 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Interparfums 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, PBH or IPAR? Prestige Consumer Healthcare has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Do institutionals & insiders have more ownership in PBH or IPAR? 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 43.7% of Interparfums shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, PBH or IPAR? Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.14B2.68$214.60M$4.2614.54Interparfums$1.45B2.08$164.36M$4.9918.82 Do analysts rate PBH or IPAR? Prestige Consumer Healthcare presently has a consensus price target of $94.80, suggesting a potential upside of 53.08%. Interparfums has a consensus price target of $162.00, suggesting a potential upside of 72.54%. Given Interparfums' stronger consensus rating and higher probable upside, analysts clearly believe Interparfums is more favorable than Prestige Consumer Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43Interparfums 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is PBH or IPAR more profitable? Prestige Consumer Healthcare has a net margin of 19.02% compared to Interparfums' net margin of 11.03%. Interparfums' return on equity of 16.45% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare19.02% 12.69% 6.79% Interparfums 11.03%16.45%11.14% SummaryInterparfums beats Prestige Consumer Healthcare on 9 of the 14 factors compared between the two stocks. Get Prestige Consumer Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBH vs. The Competition Export to ExcelMetricPrestige Consumer HealthcareMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.04B$10.60B$6.05B$21.76BDividend YieldN/A1.89%5.73%3.63%P/E Ratio14.5420.9785.0429.93Price / Sales2.6836.83588.2868.45Price / Cash11.8625.0637.5723.91Price / Book1.673.4412.674.68Net Income$214.60M$210.63M$3.32B$1.01B7 Day Performance-2.20%-2.33%-1.35%-0.71%1 Month Performance-1.68%1.36%8.09%1.18%1 Year Performance-13.08%-6.13%78.89%14.46% Prestige Consumer Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBHPrestige Consumer Healthcare4.4952 of 5 stars$61.93+0.1%$94.80+53.1%-11.6%$3.04B$1.14B14.54540IPARInterparfums4.2167 of 5 stars$93.41-1.2%$162.00+73.4%-23.0%$3.04B$1.45B18.72530HLFHerbalife4.0735 of 5 stars$8.83+2.0%$11.50+30.2%+28.1%$892.90M$4.99B2.798,600NUSNu Skin Enterprises3.6053 of 5 stars$11.47+0.9%$6.88-40.1%+73.8%$562.79M$1.73B5.713,100Analyst UpgradeUSNAUSANA Health Sciences4.5613 of 5 stars$26.61-2.0%$36.00+35.3%-40.5%$496.26M$854.50M14.781,700Earnings ReportUpcoming EarningsAnalyst RevisionNATRNature's Sunshine Products3.7073 of 5 stars$15.20-2.0%$20.50+34.9%+13.1%$273.53M$454.36M20.54850News CoveragePositive NewsMEDMEDIFAST3.4358 of 5 stars$13.94-0.4%$16.50+18.4%-23.5%$153.76M$602.46M43.55870VERUVeru2.4216 of 5 stars$4.01+5.5%$33.33+731.3%-55.5%$55.70M$16.89M-1.82230ELEstee Lauder Companies3.9425 of 5 stars$88.67+0.7%$88.55-0.1%+0.6%$31.68B$14.33B-28.2457,000Analyst UpgradeBAXBaxter International4.7528 of 5 stars$23.14-3.0%$30.11+30.1%-38.2%$12.26B$10.64B-77.1338,000BIOBio-Rad Laboratories4.1494 of 5 stars$309.67+1.4%$333.50+7.7%-10.6%$8.27B$2.57B26.407,700Positive NewsAnalyst Forecast Related Companies and Tools Related Companies IPAR Competitors HLF Competitors NUS Competitors USNA Competitors NATR Competitors MED Competitors VERU Competitors EL Competitors BAX Competitors BIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PBH) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
